Categories Earnings, Health Care

Bausch Health Companies Inc. (NYSE: BHC): Q4 2019 Earnings Snapshot

— Bausch Health Companies Inc. (NYSE: BHC) reported a loss of $4.30 per share for the fourth quarter of 2019, compared to a loss of $0.98 per share last year, vs. $1.15 per share loss expected.

Bausch Health Companies Inc. (NYSE: BHC): Q4 2019 Earnings Snapshot

— Net loss for the quarter was $1.516 billion, compared to a loss of $344 million a year earlier

— December-quarter revenues increased 5% annually to $2.22 billion, vs. $2.2 billion expected

— Revenue of Bausch + Lomb/International, the main business segment, grew 3% annually; Salix segment revenue was up 21%

— Received FDA approval for ARAZLO Lotion for the topical treatment of acne vulgaris in young adults

— Raised capital allocation for research and development by 14% in fiscal 2019, compared to last year

— Expects full-year 2020 revenues to be in the range of $8.65 billion to $8.85 billion

— Looking for adjusted EBITDA in the range of $3.50 billion to $3.65 billion for fiscal 2020

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

Lyft (LYFT) expects average ride volumes to improve through Q1 2021

Shares of Lyft Inc. (NASDAQ: LYFT) were up 8% in afternoon hours on Wednesday. The stock has gained 53% over the past 12 months and 25% since the beginning of

With new strategy in place, Target looks poised to tap growing online demand

Department store chain Target Corp. (NYSE: TGT), which has been thriving on the pandemic-driven shopping boom since early last year, maintained its strong performance during the holiday season and entered

Infographic: Dollar Tree’s (DLTR) performance in Q4

Dollar Tree (NYSE: DLTR) reported fourth-quarter financial results before the opening bell on Wednesday. The discount store reported a 7% increase in Q4 net sales to $6.7 billion. The company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top